104 related articles for article (PubMed ID: 4036688)
1. [Hormonal treatment of disseminated cancer of the prostate: results and survival obtained in a series of 60 patients].
Izquierdo Font AJ; Barnadas Molins A; Germa Lluch JR; Marcuello Gaspar E; López López JJ
Actas Urol Esp; 1985; 9(3):231-6. PubMed ID: 4036688
[No Abstract] [Full Text] [Related]
2. Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group.
Surg Gynecol Obstet; 1967 May; 124(5):1011-7. PubMed ID: 6022476
[No Abstract] [Full Text] [Related]
3. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
[TBL] [Abstract][Full Text] [Related]
4. [Combination therapy with hormonal, radiation and chemotherapy for stage C prostate cancer].
Iwasawa T; Matsumoto H
Hinyokika Kiyo; 1996 Nov; 42(11):869-74. PubMed ID: 8973937
[TBL] [Abstract][Full Text] [Related]
5. Cancer of the prostate.
N Engl J Med; 1968 Apr; 278(15):848-9. PubMed ID: 5642506
[No Abstract] [Full Text] [Related]
6. Endocrine treatment of cancer of the prostate.
Madsen PO; Pedersen JF; Knuth OE
Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
[No Abstract] [Full Text] [Related]
7. Studies on extragonadal androgen: hormonal changes of the prostatic cancer patients on antiandrogenic therapy after orchiectomy.
Fukuda Y
Kobe J Med Sci; 1968 Mar; 14(1):1-23. PubMed ID: 5674440
[No Abstract] [Full Text] [Related]
8. [Hormone therapy of cancer of the prostate gland].
Madsen PO; Pedersen IF; Knut OE
Urol Nefrol (Mosk); 1970; 35(3):25-8. PubMed ID: 4915239
[No Abstract] [Full Text] [Related]
9. Successful treatment of poor prognostic patients with advanced prostatic carcinoma with the association of diethylstilbestrol and cyclophosphamide.
Germá Lluch JR; Marcuello Gaspar E; de Andrés Basauri L; López Pousa A; López López JJ
Rev Esp Oncol; 1982; 29(2):317-24. PubMed ID: 7188232
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of clinically localized prostatic cancer--endocrine therapy].
Hirano A
Hinyokika Kiyo; 1996 Oct; 42(10):829-32. PubMed ID: 8951483
[TBL] [Abstract][Full Text] [Related]
11. [Hormone therapy in carcinoma of the prostate].
Marberger H
Wien Klin Wochenschr; 1966 Jul; 78(29):512-4 passim. PubMed ID: 5992834
[No Abstract] [Full Text] [Related]
12. Prognostic significance of prostate-specific antigen levels two months after hormonal manipulation of metastatic prostate cancer.
Kawakami S; Takagi K; Yonese J; Ueda T; Fukui I; Kawai T
Eur Urol; 1997; 32(1):58-63. PubMed ID: 9266233
[TBL] [Abstract][Full Text] [Related]
13. Bilateral orchiectomy in the management of stage D-2 prostate cancer.
Guinan P; Firfer R; Targonski P; Rubenstein M
Int Surg; 1993; 78(1):73-5. PubMed ID: 8473090
[TBL] [Abstract][Full Text] [Related]
14. [Combined hormone and chemotherapy for the patients with advanced prostate cancer].
Uekado Y; Hirano A; Inagaki T; Hiroi A; Watanabe T
Gan To Kagaku Ryoho; 1995 Jul; 22(8):1041-5. PubMed ID: 7611755
[TBL] [Abstract][Full Text] [Related]
15. [Prostatic cancer and its prognosis under Honvan treatment].
Gaca A; Köhnlein HE; Köttgen H
Med Welt; 1968 Apr; 15():961-7. PubMed ID: 5717752
[No Abstract] [Full Text] [Related]
16. Effect of diethylstilbestrol on blood glucose of prostatic cancer patients.
Sotaniemi EA; Kontturi M; Larmi TK
Ann Chir Gynaecol Fenn; 1973; 62(2):82-6. PubMed ID: 4717366
[No Abstract] [Full Text] [Related]
17. Carcinoma of the prostate: neoadjuvant hormonotherapy followed by radiotherapy.
Scalliet P
Acta Urol Belg; 1996 May; 64(2):63-4. PubMed ID: 8701815
[No Abstract] [Full Text] [Related]
18. Current status of endocrine therapy for prostate cancer in Japan analysis of primary androgen deprivation therapy on the basis of data collected by J-CaP.
Hinotsu S; Akaza H; Usami M; Ogawa O; Kagawa S; Kitamura T; Tsukamoto T; Naito S; Namiki M; Hirao Y; Murai M; Yamanaka H;
Jpn J Clin Oncol; 2007 Oct; 37(10):775-81. PubMed ID: 17965423
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients.
Grande M; Carlström K; Rozell BL; Stege R; Pousette A
Clin Cancer Res; 2000 May; 6(5):1790-5. PubMed ID: 10815899
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
Miyake H; Hara I; Eto H
BJU Int; 2005 Oct; 96(6):791-5. PubMed ID: 16153202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
